雜志介紹

Clinical Lung Cancer雜志介紹

《Clinical Lung Cancer》是一本以English為主的未開放獲取國際優秀期刊，中文名稱臨床肺癌，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.3，最新CiteScore 指數為7。

本刊近期中國學者發表的論文主要有：

• Pathological Stage N1 Limited-Stage Small-Cell Lung Cancer Patients Can Benefit From Surgical Resection

  Author: Yu, Lian; Xu, Jianlin; Qiao, Rong; Han, Baohui; Zhong, Hua; Zhong, Runbo

• The comparison of Lobe-Specific or Systematic Mediastinal Lymph Node Dissection for Early-Stage Lung Adenocarcinoma With Consolidation Tumor Ratio Over 0.5

  Author: Sui, Qihai; Yang, Huiqiang; Yin, Jiacheng; Li, Ming; Jin, Xing; Chen, Zhencong; Jiang, Wei; Wang, Qun

• The Value of Radiotherapy in Patients With Resectable Stage IIIA Non-Small-Cell Lung Cancer in the Era of Individualized Treatment: A Population-Based Analysis

  Author: Liu, Bohao; Wang, Zhiyu; Zhao, Heng; Gao, Shan; Wang, Hongyi; Zhang, Yanpeng; Fan, Kun; Tao, Runyi; Li, Yixing; Feng, Jinteng; Sun, Yuchen; Zhang, Jia; Zhang, Guangjian

• Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy

  Author: Fu, Jing; Tong, Yuyang; Xu, Ziguang; Li, Yaonan; Zhao, Ya; Wang, Tao; Li, Cuidan; Cang, Shundong

英文介紹

Clinical Lung Cancer雜志英文介紹

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.